ClinicalTrials.gg
Not yet recruitingNCT07755631BASIC-SUpdated Aug 25, 2026

The BASIC-S Feasibility Study for Vascular Risk Reduction

An interventional study of BASIC-S Intervention and Standard / Usual Care in Hypertension (HTN), Vascular Diseases and Stroke, sponsored by Andrew Appleton. Not yet recruiting at 1 site in Canada. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-25.

Sponsored by Andrew Appleton · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Vascular risk factors drive stroke, heart disease, and dementia, but translating lifestyle guidelines into routine clinical care remains challenging. To address this, we developed BASIC-S (Blood Pressure, Activity, Sleep, Interaction, Consumption, and Support), a framework targeting Blood pressure, Activity, Sleep, Interaction (socially), Consumption (nutrition), and Support using partner support and motivational interviewing. This individual-focused approach bypasses the logistical and financial barriers of complex clinical interventions by using sustained behavioral science to support gradual lifestyle changes. This study is a single-center, mixed-methods, cluster-randomized pilot trial evaluating the feasibility of the BASIC-S protocol in an occupational setting. A maximum of 60 households (120 participants) will be randomized 1:1 to either the BASIC-S intervention (motivational coaching, secure video check-ins, automated text messages, and a digital workbook) or standard care. Outcomes will assess feasibility, acceptability, and the validity of new tracking metrics to inform a future full-scale trial.

Read the detailed description

Background and Rationale:

High blood pressure, inactivity, poor sleep, social isolation, and unhealthy diets drive stroke, heart disease, and dementia. As dementia rates plateau and cardiovascular diseases rise, current public health strategies are stalling. The 2025 Hypertension Canada guidelines lowered the threshold for hypertension to 130/80 mm Hg (target \<130 mm Hg), vastly increasing the population needing management. However, translating lifestyle risk reduction into routine care is hindered by fragmented clinical workflows and a lack of behavioral support.

To address this, we developed BASIC-S (Blood Pressure, Activity, Sleep, Interaction, Consumption, and Support) framework. Grounded in partnering and motivational interviewing principles, BASIC-S is designed to bridge the evidence-to-practice implementation gap and support the translation of research into real-world health behavior change.

Study Design and Setting:

This study is a single-center, mixed-methods, cluster-randomized pilot trial conducted at the London Health Sciences Centre (LHSC). Randomization occurs at the household level, enrolling either individual employees or employee-partner pairs. Households are randomized 1:1 to either the BASIC-S intervention or standard care for six months.

Statistical Analysis Plan:

Analyses will be conducted at the individual participant level, with the primary timepoint for comparison being 6 months. To account for the potential clustering effects of households, continuous outcome data will be analyzed using mixed models for repeated measures, incorporating a random intercept for the household. Sensitivity to the normality assumptions of continuous outcomes will be assessed using rank-based methods designed for cluster-randomized trials. Discrete outcomes will be evaluated using a generalized estimating equations (GEE) approach alongside applicable rank-based methods. The standard deviation of the change scores and the intraclass correlation coefficient (ICC) will be estimated to inform power calculations for the future definitive trial. To assess convergent validity, correlation coefficients (e.g., Pearson or Spearman) will be calculated between the novel indices and established psychometric reference scales. Qualitative transcripts will undergo thematic analysis by two independent coders to systematically classify barriers, facilitators, and overall acceptability.

02

Conditions studied

  • Hypertension (HTN)
  • Vascular Diseases
  • Stroke
  • Dementia
  • Cardiovascular Risk Factor
  • Cognitive Decline

Keywords

  • Lifestyle Intervention
  • Motivational Interviewing
  • Primary Prevention
  • Behavioral Medicine
  • Brain Health
  • Cognition
  • Mental Health
  • Social Activity
  • Social Isolation
  • Physical Activity
  • Blood Pressure
  • Activity
  • Sleep
  • Interaction
  • Consumption
  • Support
  • Partnering
03

In context

Hypertension

6,114 studies on the registry are indexed under Hypertension; 912 are open to participants now.

This study's planned enrollment of 120 is above the median of 100 across 4,575 interventional studies indexed under Hypertension.

Browse Hypertension studies →

Lead sponsor

This is the only study on the registry with Andrew Appleton as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18 years and older currently employed at or recently retired from the London Health Sciences Centre (LHSC) or Western University (with an operational focus on pre-retirees aged 50 years and older).
  • The primary applicant (not their partner, if applicable) must be within two years before or after their retirement date.
  • Spouse or cohabitating partner of an enrolled primary participant. Cohabitating partners may include a common-law partner, adult child, close friend, or roommate who lives with the primary participant and shares common health goals. Enrollment of partners is optional but strongly encouraged.
  • Capable of providing .
  • Has access to a mobile device capable of receiving Short Message Service (SMS) communications and viewing Portable Document Format (PDF) documents.
  • Physically able to safely engage in light-to-moderate intensity physical activity.

Exclusion criteria

Exclusion Criteria:

  • Medical conditions that preclude safe participation in physical activity (for instance, unstable angina, uncontrolled arrhythmia, severe heart failure) without physician clearance.
  • Active or unstable psychiatric illness, defined as hospitalization for psychiatric care within the preceding 6 months or modifications to antipsychotic or mood-stabilizing pharmacotherapy within the preceding 3 months. Participants with stable, medically managed psychiatric conditions remain eligible.
  • Severe cognitive impairment that compromises the ability to provide or independently use study-related technology.
  • Inability to read and understand English sufficiently to provide informed consent and complete study procedures.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    BASIC-S Intervention Group

    Households allocated to this arm receive a multicomponent behavioral lifestyle program grounded in the Information-Motivation-Behavioral Skills (IMB) model.

    Behavioral: BASIC-S Intervention

  • Active comparator
    Standard Care (Usual Care) Group

    Households allocated to this arm receive pure usual care to serve as a real-world comparator, continuing their routine healthcare and access to institutional wellness resources.

    Behavioral: Standard / Usual Care

Interventions

  • BehavioralBASIC-S Intervention

    Participants attend an initial 45-minute goal-setting session with a certified wellness coach. Subsequent support includes an interactive BASIC-S Digital Workbook, automated twice-weekly motivational and educational SMS messages via Twilio, and biweekly (every two weeks) 15-20 minute face-to-face secure video booster sessions (via Microsoft Teams) using motivational interviewing. Intervention households receive a validated automated home blood pressure monitor at baseline.

  • BehavioralStandard / Usual Care

    Participants are instructed to continue routine medical follow-up as directed by their primary care providers. To serve as a true comparator, no study-specific behavioral prompts or educational materials are provided during the active 6-month study period. To maximize ethical benefit (waitlist control), control households receive the complete BASIC-S Digital Workbook and a validated automated home blood pressure monitor at the conclusion of their 6-month follow-up visit.

    Also known as: Waitlist, Control

06

What researchers measure

Primary outcomes

  1. Recruitment Rate

    Feasibility operationalized as the proportion of eligible individuals approached who consent to enroll in the trial.

    Time frame: At the conclusion of the 5-month recruitment period.

  2. Retention Rate

    Feasibility operationalized as the proportion of enrolled participants who complete the final 6-month follow-up assessment.

    Time frame: At 6 months post-randomization.

Secondary outcomes

  1. Change in Integral Brain Health (IBH) Index Score

    A 3-item self-report scale assessing perceived cognition, mood, and social connection. Each item is scored 1-5. Total scores range from 3 to 15, with higher scores indicating better self-perceived brain health.

    Time frame: Baseline, 3 Months, 6 Months.

  2. Change in BASIC-S Implementation Index Score

    A 5-domain self-report scale quantifying adherence to core lifestyle domains (Blood pressure, Activity, Sleep, Interaction, and Consumption). Scored using a hierarchically weighted system based on goal attainment (0.0 to 3.0 points per domain). Total score ranges from 0 to 15, with higher scores indicating greater lifestyle adherence. Support serves as a distinct implementation enhancer (scored separately from 0.0 to 3.0).

    Time frame: Baseline, 3 Months, 6 Months.

  3. Change in Systolic Blood Pressure

    Measured using a standardized automated oscillometric device (average of 3 readings after a 5-minute seated rest). The unit of measure is millimeters of mercury (mmHg).

    Time frame: Baseline, 3 Months, 6 Months.

  4. Change in Subjective Well-Being (WHO-5)

    Measured using the World Health Organization-5 (WHO-5) Well-Being Index. The scale contains 5 items, each scored from 0 to 5. Total raw scores range from 0 to 25 and are multiplied by 4 to generate a percentage score (0-100), with higher scores representing better well-being.

    Time frame: Baseline and 6 Months.

  5. Change in Subjective Cognitive Function (PROMIS)

    Measured using the Patient-Reported Outcomes Measurement Information System (PROMIS) Cognitive Function Short Form 4a. Raw scores range from 4 to 20, which are translated into standardized T-scores. Higher scores indicate better cognitive function.

    Time frame: Baseline and 6 Months

  6. Change in Sleep Disturbance (PROMIS)

    Measured using the Patient-Reported Outcomes Measurement Information System (PROMIS) Sleep Disturbance Short Form 4a. Raw scores range from 4 to 20, translated into standardized T-scores. Higher scores indicate greater sleep disturbance.

    Time frame: Baseline and 6 Months

  7. Change in Physical Activity (PAVS)

    Measured using the Physical Activity Vital Sign (PAVS). Calculated by multiplying the reported days of physical activity per week by the reported minutes per day, yielding a total of moderate-to-vigorous physical activity minutes per week.

    Time frame: Baseline and 6 Months

  8. Change in Social Connectivity (LSNS-6)

    Measured using the Lubben Social Network Scale-6 (LSNS-6). Contains 6 items scored from 0 to 5. Total scores range from 0 to 30, with higher scores indicating stronger social networks and lower risk of isolation.

    Time frame: Baseline and 6 Months

  9. Change in Dietary Quality (STC)

    Measured using the 8-item Starting The Conversation (STC) Dietary Tool. Total scores range from 0 to 16, with higher scores indicating poorer dietary quality (greater consumption of unhealthy foods).

    Time frame: Baseline and 6 Months

07

Study locations

1 site
  • London Health Sciences Centre (LHSC)
    London, Ontario N6A 3K7, Canada
    • · Contactandrew.appleton@lhsc.on.ca · 519-685-8500
    • Andrew J Appleton, MD. · Principal investigator
    • Vladimir Hachinski, MD, DSc · Sub investigator
    • Abolfazl Avan, MD, PhD. · Sub investigator
    • George K Dresser, MD, PhD. · Sub investigator
    • William A Fisher, PhD · Sub investigator
    • Jamie A Seabrook, PhD · Sub investigator
    • Guangyong Zou, PhD · Sub investigator
    • Shawn N Whitehead, PhD · Sub investigator
08

References and documents

Publications

  • Avan A, Hachinski V. Global, regional, and national trends of dementia incidence and risk factors, 1990-2019: A Global Burden of Disease study. Alzheimers Dement. 2023 Apr;19(4):1281-1291. doi: 10.1002/alz.12764. Epub 2022 Aug 31. PubMed 36044376 ↗
  • Hachinski V. Brain Health-Curbing Stroke, Heart Disease, and Dementia: The 2020 Wartenberg Lecture. Neurology. 2021 Aug 10;97(6):273-279. doi: 10.1212/WNL.0000000000012103. Epub 2021 Apr 21. PubMed 33883239 ↗
  • Avan A, Andersen R, Andersson N, Frisbee SJ, Singh S, Zhong S, Rogers KA, Whitehead SN, Hachinski V. An operational measurement of brain health: the ABCDS framework. Lancet Neurol. 2025 Apr;24(4):291-292. doi: 10.1016/S1474-4422(25)00076-6. No abstract available. PubMed 40120612 ↗

Individual participant data

Plan to share: Yes — De-identified individual participant data (IPD) collected during the trial will be made available to qualified researchers who provide a methodologically sound proposal to achieve aims outlined in the approved proposal.

Supporting information: Study protocol, Statistical analysis plan

Time frame: Data will become available beginning 9 months and ending 36 months following article publication.

Access criteria: Data access requests will be reviewed by the Principal Investigator and the study steering committee. Requestors must provide a formal research proposal and statistical analysis plan. To protect the privacy of this occupational cohort, access will require a formal Data Sharing Agreement (DSA) approved by the London Health Sciences Centre Research Institute (LHSCRI) contracts office. Proposals should be directed to the Principal Investigator at andrew.appleton@lhsc.on.ca.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Jul 2027, 9 months later.

Of 1,403 non-industry interventional studies with no phase under Hypertension, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 9 months is below that.

Counting every sponsor, half of 1,498 studies reached it within 23 months; a quarter within 10 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 5, 2026
First posted
Aug 10, 2026
StartEst.
Oct 1, 2026
Primary completionEst.
Jul 1, 2027
CompletionEst.
Oct 1, 2027
Last update
Aug 25, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 25, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07755631
Lead sponsor
Andrew Appleton
Collaborators
Academic Medical Organization of Southwestern Ontario
Responsible party
Andrew Appleton (LHSC-University Hospital (LHSC-UH) Site Chief, Associate Professor, Deputy Program Director for the Department of Medicine (DOM) Internal Medicine (IM4) Program, Principal Investigator, London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's) — Sponsor-investigator
First posted
Aug 10, 2026
Start date
Oct 1, 2026 (estimated)
Primary completion
Jul 1, 2027 (estimated)
Completion
Oct 1, 2027 (estimated)
Last update
Aug 25, 2026

Study contacts

Andrew J Appleton, MD, FRCPC.
Contact
andrew.appleton@lhsc.on.ca
519-685-8500 ext. 33071
Abolfazl Avan, MD, PhD.
Contact
aavan2@uwo.ca

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion